Fungal infections have historically been, and remain important causes of transplant-related
morbidity in recipients of hematopoietic stem cell transplant (HSCT). However, there have …

The advent of bone marrow transplant has opened doors to a different approach and offered
a new treatment modality for various hematopoietic stem-cell-related disorders. Since the …

Invasive fungal infections are an important cause of morbidity and mortality in hematopoietic
stem cell transplant and solid organ transplant recipients. Evolving transplant modalities and …

Blood and marrow transplantation (BMT) is increasingly used to treat malignant and
nonmalignant diseases. Despite significant advances in the management of transplant …

The practice of hematopoietic stem cell transplantation (HSCT) has undergone many
changes that affect the likelihood that a given patient would develop an invasive fungal …

Allogeneic hematopoietic cell transplant (HCT) recipients are at increased risk of invasive
fungal infections (IFI), which are associated with a high mortality rate. We evaluated the …

Background Allogeneic hematopoietic stem cell transplant (HSCT) recipients experience an
increased risk for invasive fungal diseases (IFDs). Methods This retrospective cohort study at …

The changing face of invasive fungal infections in hematopoi... : Current Opinion in
Oncology The changing face of invasive fungal infections in hematopoietic cell transplant …

Objectives. Invasive fungal infections (IFIs) remain a major cause of infection‐related
morbidity and mortality following hematopoietic stem cell transplantation (HSCT). Patients …

Fungal infections are currently a leading cause of infectious morbidity and mortality in
patients undergoing allogeneic blood and marrow transplantation (BMT). Although the …